Biolife Solutions stock hits 52-week high at 35.36 USD
stock reached a 52-week high of $35.36, marking a significant milestone for the company. The stock has surged nearly 98% from its 52-week low of $17.86, though BLFS">InvestingPro data suggests the RSI indicates overbought territory.
Reported by 2 outlets — Investing.com · Company News. See all sources ↓
stock reached a 52-week high of $35.36, marking a significant milestone for the company. The stock has surged nearly 98% from its 52-week low of $17.86, though BLFS">InvestingPro data suggests the RSI indicates overbought territory. Over the past year, the stock has experienced a notable increase, with a 1-year change of 44%. The momentum has been particularly strong in recent months, with a 57% gain over the past six months alone.
Read the full report at Investing.com · Company News ↗
Why it matters
2 outlets are covering this world story — one to watch as reporting develops.
- What's the story?
- stock reached a 52-week high of $35.36, marking a significant milestone for the company. The stock has surged nearly 98% from its 52-week low of $17.86, though BLFS">InvestingPro data suggests the RSI indicates overbought territory.
- How widely is it covered?
- 2 outlets, average source rating 5.0/10.
- When was it last updated?
- just now ago.
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card1 outlet1CoverageScouting report
Biolife Solutions stock hits 52-week high at 35.36 USD
Sources1TypeCoverageInvesting.com · Company News